Author Archive

You are here: / Ahmed Ghazi, Rachel Melnyk, Andrew J. Hung, Justin Collins, Ashkan Ertefaie,...
Ahmed Ghazi, Rachel Melnyk, Andrew J. Hung, Justin Collins, Ashkan Ertefaie, Patrick Saba, Pratik Gurung, Thomas Frye, Hani Rashid, Guan Wu, Alex Mottrie, Tony Costello, Prokar Dasgupta, Jean Joseph

About Ahmed Ghazi, Rachel Melnyk, Andrew J. Hung, Justin Collins, Ashkan Ertefaie, Patrick Saba, Pratik Gurung, Thomas Frye, Hani Rashid, Guan Wu, Alex Mottrie, Tony Costello, Prokar Dasgupta, Jean Joseph

This author has not written his bio yet.
But we are proud to say that Ahmed Ghazi, Rachel Melnyk, Andrew J. Hung, Justin Collins, Ashkan Ertefaie, Patrick Saba, Pratik Gurung, Thomas Frye, Hani Rashid, Guan Wu, Alex Mottrie, Tony Costello, Prokar Dasgupta, Jean Joseph contributed 1479 entries already.
Edit the profile description here.

Entries by Ahmed Ghazi, Rachel Melnyk, Andrew J. Hung, Justin Collins, Ashkan Ertefaie, Patrick Saba, Pratik Gurung, Thomas Frye, Hani Rashid, Guan Wu, Alex Mottrie, Tony Costello, Prokar Dasgupta, Jean Joseph

Multi‐institutional validation of a Perfused Robot‐Assisted Partial Nephrectomy Procedural Simulation platform utilizing clinically relevant objective metrics of simulators (CROMS)

/by

Abstract Background Robot‐assisted partial nephrectomy (RAPN) is becoming the standard treatment for small renal masses. However, the availability of realistic validated, non‐biohazardous procedural platform for training are lacking. Objective The multi‐institutional validation of a high‐fidelity, perfused, inanimate, simulation platform for RAPN utilizing incorporated clinically relevant objective metrics of simulation (CROMS) applying modern validity standards. Materials […]

Intraoperative aerosol viral transmission in minimally invasive surgery: A scoping review and impact on clinical guidelines and practice during the onset of the COVID‐19 pandemic

/by

Abstract Background Robot‐assisted partial nephrectomy (RAPN) is becoming the standard treatment for small renal masses. However, the availability of realistic validated, non‐biohazardous procedural platform for training are lacking. Objective The multi‐institutional validation of a high‐fidelity, perfused, inanimate, simulation platform for RAPN utilizing incorporated clinically relevant objective metrics of simulation (CROMS) applying modern validity standards. Materials […]

A novel tool to predict functional outcomes after RARP and the value of additional surgery for incontinence

/by

Abstract Objectives To develop and validate a model to predict 12‐month continence status after robot assisted radical prostatectomy (RARP) from preoperative and 3‐month postoperative data; this model could help in informing patients on their individualized risk of urinary incontinence (UI) after radical prostatectomy in order to choose the best treatment option. Materials and methods Data […]

COVID‐19 and urology in Australia and New Zealand: uncertain times

/by

Abstract Background Robot‐assisted partial nephrectomy (RAPN) is becoming the standard treatment for small renal masses. However, the availability of realistic validated, non‐biohazardous procedural platform for training are lacking. Objective The multi‐institutional validation of a high‐fidelity, perfused, inanimate, simulation platform for RAPN utilizing incorporated clinically relevant objective metrics of simulation (CROMS) applying modern validity standards. Materials […]

Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population‐based data

/by

Abstract Background Robot‐assisted partial nephrectomy (RAPN) is becoming the standard treatment for small renal masses. However, the availability of realistic validated, non‐biohazardous procedural platform for training are lacking. Objective The multi‐institutional validation of a high‐fidelity, perfused, inanimate, simulation platform for RAPN utilizing incorporated clinically relevant objective metrics of simulation (CROMS) applying modern validity standards. Materials […]

Not all prostate cancer is the same – patient perceptions: an Asia‐Pacific region study

/by

Abstract Background Robot‐assisted partial nephrectomy (RAPN) is becoming the standard treatment for small renal masses. However, the availability of realistic validated, non‐biohazardous procedural platform for training are lacking. Objective The multi‐institutional validation of a high‐fidelity, perfused, inanimate, simulation platform for RAPN utilizing incorporated clinically relevant objective metrics of simulation (CROMS) applying modern validity standards. Materials […]

Issue Information

/by

Abstract Background Robot‐assisted partial nephrectomy (RAPN) is becoming the standard treatment for small renal masses. However, the availability of realistic validated, non‐biohazardous procedural platform for training are lacking. Objective The multi‐institutional validation of a high‐fidelity, perfused, inanimate, simulation platform for RAPN utilizing incorporated clinically relevant objective metrics of simulation (CROMS) applying modern validity standards. Materials […]

A clinical pathway for the management of Peyronie’s disease: integrating clinical guidelines from the International Society of Sexual Medicine, American Urological Association and European Urological Association

/by

Abstract Background Robot‐assisted partial nephrectomy (RAPN) is becoming the standard treatment for small renal masses. However, the availability of realistic validated, non‐biohazardous procedural platform for training are lacking. Objective The multi‐institutional validation of a high‐fidelity, perfused, inanimate, simulation platform for RAPN utilizing incorporated clinically relevant objective metrics of simulation (CROMS) applying modern validity standards. Materials […]

Use of a trizonal schema to assess targeting accuracy in prostatic fusion biopsy

/by

Objectives To externally validate the currently available nomograms for predicting lymph node invasion (LNI) in patients with prostate cancer (PCa) and to assess the potential risk of complications of extended pelvic lymph node dissection (ePLND) when using the recommended threshold. Methods A total of 14 921 patients, who underwent radical prostatectomy with ePLND at eight European […]

© 2024 BJU International. All Rights Reserved.